Patents for C07D 271 - Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms (7,144) |
---|
03/13/2013 | CN101304982B Process for the preparation of benzotriazepine derivatives |
03/12/2013 | US8395041 Photoelectric conversion element and solor cell |
03/12/2013 | US8394966 Crystalline forms of 3-[5-(2-fluorophenyl)-[1,2,4]oxadiazol-3-yl]-benzoic acid |
03/07/2013 | US20130060025 Certain heterocycles, compositions thereof, and methods for their use |
03/05/2013 | US8389735 Oxadiazole derivative, and light emitting element, light emitting device, and electronic device using the oxadiazole derivative |
03/05/2013 | US8389509 Substituted pyrazole compounds |
02/28/2013 | US20130053416 3-heteroaroylamino-propionic acid derivatives and their use as pharmaceuticals |
02/27/2013 | EP2562157A1 Heteroaryl (alkyl) dithiocarbamate compounds, preparation methods and uses thereof |
02/27/2013 | CN102942534A Preparation of drug intermediate 4-formoxyl benzofuroxan |
02/26/2013 | US8383654 Heterocyclic antagonists of prostaglandin D2 receptors |
02/26/2013 | US8383622 Nitrogen-containing heterocyclic derivative having 11β-hydroxysteroid dehydrogenase type I inhibitory activity |
02/21/2013 | WO2013024843A1 Ceramide derivative and golgi apparatus-labeling fluorescent probe using same |
02/20/2013 | EP2559690A1 Modulators of indoleamine 2,3-dioxygenase and methods of using the same |
02/20/2013 | EP2559689A1 Preparation process for crystalline forms of 3-[5-(2-fluorophenyl)-[1,2,4]oxadiazol-3-yl]benzoic acid |
02/19/2013 | US8377975 Oxadiazole derivatives for the treatment of diabetes |
02/13/2013 | CN102924399A 2,5-diaryl-1,3,4-oxadiazole compounds and preparation method and application thereof |
02/13/2013 | CN102924323A Neutralization improvement method for production of oxadiazon |
02/07/2013 | US20130035360 Novel water soluble furoxan derivatives having antitumor activity |
02/07/2013 | US20130035312 Cathepsin cysteine protease inhibiors |
02/05/2013 | US8367841 Processes for the preparation of 1,2,4-oxadiazole benzoic acids |
02/05/2013 | US8367840 Composition for treating infectious diseases caused by Helicobacter |
02/05/2013 | CA2591033C Heterocyclic aspartyl protease inhibitors |
02/05/2013 | CA2521992C 1,2,4-oxadiazole benzoic acid compounds |
01/31/2013 | WO2013014204A2 3-heteroaroylamino-propionic acid derivatives and their use as pharmaceuticals |
01/31/2013 | US20130026459 Polymer compound |
01/31/2013 | CA2841905A1 3-heteroaroylamino-propionic acid derivatives and their use as pharmaceuticals |
01/29/2013 | US8362048 Selective sphingosine 1 phosphate receptor modulators and methods of chiral synthesis |
01/29/2013 | US8362047 Anti-cancer agents based on 4-(hetero)Ary1-1,2,5-oxadiazol-3-yl Amino derivatives and a method of making |
01/22/2013 | US8357706 Sphingosine 1 phosphate receptor modulators and methods of chiral synthesis |
01/22/2013 | US8357705 Substituted cyclohexyldiamines |
01/22/2013 | CA2565695C Certain chemical entities and compositions for use in the treatment of a cellular proliferative disease or disorder |
01/17/2013 | WO2013008162A1 Novel trifluoromethyl-oxadiazole derivatives and their use in the treatment of disease |
01/17/2013 | US20130018066 Heterocyclic aspartyl protease inhibitors |
01/17/2013 | US20130018055 New aryl-benzocycloalkyl amide derivatives |
01/17/2013 | CA2841113A1 Novel trifluoromethyl-oxadiazole derivatives and their use in the treatment of disease |
01/16/2013 | CN102870788A Application of 1,3,4-oxadiazole thioethers as herbicide |
01/15/2013 | US8354436 IL17 and IFN-gamma inhibition for the treatment of autoimmune inflammation |
01/09/2013 | CN101522645B Phenyl derivatives and their use as immunomodulators |
01/08/2013 | US8350027 Dual-acting pyrazole antihypertensive agents |
01/03/2013 | WO2013000395A1 Novel histone deacetylase inhibitor of benzamides and use thereof |
01/03/2013 | WO2012116151A3 Vinyl -aryl - sulfones for use in peritoneal carcinomatosis |
01/03/2013 | US20130005771 Oxadiazole compounds, their preparation and use |
01/02/2013 | EP2539328A1 Novel water soluble furoxan derivatives having antitumor activity |
01/02/2013 | EP2539327A1 Oxadiazole compounds, their preparation and use |
01/02/2013 | EP2539323A1 Compounds as bradykinin b1 antagonists |
01/02/2013 | CN102850369A Nitrogen monoxide donor-type oridonin 1,4-hydroxyl-modified derivative, and its preparation method and application |
01/01/2013 | US8343639 Organic semiconductor material and light-emitting element, light-emitting device, lighting system, and electronic device using the same |
12/27/2012 | WO2012176856A2 Pesticide |
12/27/2012 | WO2012129564A3 Proteasome chymotrypsin-like inhibition using pi-1833 analogs |
12/27/2012 | US20120329840 Novel modulators of sphingosine phosphate receptors |
12/27/2012 | US20120329839 Novel modulators of sphingosine phosphate receptors |
12/27/2012 | US20120329838 Novel modulators of sphingosine phosphate receptors |
12/27/2012 | US20120329649 Pesticidal compositions and processes related thereto |
12/26/2012 | CN102838442A 9-alkenylfluorene derivatives and application thereof |
12/26/2012 | CN101648923B Hydroxamic acid compound used as histone deacetylase inhibitor and application thereof |
12/25/2012 | US8338614 e.g. 2-[5-(5-methyl-1,3-diphenyl-1H-pyrazol-4-yl)-1,3,4-oxadiazol-2-yl]-1-phenylpropan-2-amine; neurodegenerative diseases; preventing the formation of insoluble amyloid beta and arresting the production of amyloid beta |
12/25/2012 | US8338418 Dual-acting antihypertensive agents |
12/20/2012 | WO2012110833A3 Fluorescence modulators |
12/20/2012 | US20120323015 Oxadiazole Derivative, Light-Emitting Element Material, Light-Emitting Element, Light-Emitting Device, and Electronic Device |
12/19/2012 | EP2533783A1 Compounds and methods |
12/19/2012 | CN102827098A 1,3,4-oxadiazole derivative and preparation method and application thereof |
12/19/2012 | CN101910141B A novel alpha-(N-sulfonamido)acetamide compound as an inhibitor of beta amyloid peptide production |
12/18/2012 | US8334316 Substituted organosulfur compounds and methods of using thereof |
12/18/2012 | US8334309 Heterocyclic indazole derivatives |
12/12/2012 | EP2532653A1 Benzo[1,2,4]triazines as protein kinase modulators |
12/12/2012 | CN102816128A Heterocyclic group contained amino-methanol derivative, its salt, its synthetic method and its use |
12/12/2012 | CN102002014B Preparation method of substituted 1,3,4-diazole-2-(3H)-ketone |
12/05/2012 | EP2528890A1 Aminocyclohexanes and aminotetrahydropyrans and related compounds as gamma-secretase modulators |
12/04/2012 | US8324254 Oxadiazole substituted indazole derivatives for use as sphingosine 1-phosphate (S1P) agonists |
11/29/2012 | WO2012162635A1 Metabotropic glutamate receptors 5 modulators and methods of use thereof |
11/29/2012 | CA2837312A1 Metabotropic glutamate receptor 5 modulators and methods of use thereof |
11/28/2012 | CN102803238A Oxadiazole derivatives |
11/27/2012 | US8318748 Cathepsin cysteine protease inhibitors |
11/27/2012 | CA2551324C Heteroaryl-ureas and their use as glucokinase activators |
11/21/2012 | CN102786375A 9-alkyl alkenyl-2,7-diaryl fluorene derivate and application of 9-alkyl alkenyl-2,7-diaryl fluorene derivate |
11/20/2012 | US8314091 N-benzyl,N'-arylcarbonylpiperazine derivatives |
11/15/2012 | US20120289698 Certain heterocycles, compositions thereof, and methods for their use |
11/14/2012 | CN1951947B Organometallic complex, and light-emitting element and light-emitting device using the same |
11/14/2012 | CN102781916A Compounds as bradykinin B1 antagonists |
11/14/2012 | CN102781910A Alkylamine derivative |
11/13/2012 | CA2539467C Non-peptide agonists and antagonists of adrenomedullin and gastric releasing peptide |
11/13/2012 | CA2505299C Novel biaromatic compunds which activate ppary type receptors, and use therof in cosmetic or pharmaceutical compositions |
11/08/2012 | WO2012125832A3 Antimicrobial agents |
11/08/2012 | US20120283287 Certain chemical entities, compositions, and methods |
11/07/2012 | CN102770410A Novel azomethine oligomer |
11/01/2012 | WO2012147764A1 5-membered ring aromatic heterocyclic derivative having npy y5 receptor antagonistic activity |
11/01/2012 | US20120277234 1,2,4-oxadiazole benzoic acids |
11/01/2012 | CA2834429A1 5-membered ring aromatic heterocyclic derivative having npy y5 receptor antagonistic activity |
10/31/2012 | CN102757402A Synthesizing method of 1,3,4-oxadiazole organic electroluminescent material |
10/31/2012 | CN101426775B Oxadiazolidinedione compound |
10/30/2012 | US8299264 Method for producing oxadiazolinone compound and intermediate thereof |
10/26/2012 | WO2012145361A1 Modulators of the gpr119 receptor and the treatment of disorders related thereto |
10/26/2012 | WO2012142671A1 Aromatic amides and uses thereof |
10/24/2012 | CN102746253A Oxadiazole derivative containing veratraldehyde and preparation method thereof |
10/24/2012 | CN102746252A Synthetic method of 3-chloro-1,2,4-oxadiazole |
10/18/2012 | US20120264717 Compounds, Compositions and Methods Comprising Oxadiazole Derivatives |
10/16/2012 | US8288371 Ortho pyrrolidine, benzyl-substituted heterocycle CCR1 antagonists for autoimmune diseases and inflammation |
10/16/2012 | US8288316 N-(1,2,5-oxadiazol-3-yl)benzamides and their use as herbicides |
10/04/2012 | US20120253040 Oxadiazole derivative having endothelial lipase inhibitory activity |
10/04/2012 | US20120252776 C4 Monomethyl Triterpenoid Derivatives and Methods of Use Thereof |